RISE Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV
Launched by BOSTON UNIVERSITY · Apr 1, 2025
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to improve treatment for veterans who have experienced intimate partner violence (IPV), which can lead to issues like depression and post-traumatic stress disorder (PTSD). The research will compare two different counseling methods: one that includes up to eight sessions covering topics like social support and health effects, and another that consists of a single session focused on education about IPV, safety, and available resources. The goal is to find out which approach helps patients feel more in control of their health and well-being.
To be eligible for this study, participants must be veterans receiving care at a specific clinic and have experienced physical, emotional, or sexual IPV in the past year. They should also be able to give permission for their sessions to be recorded. Those who have serious mental health conditions or thoughts of harming themselves or others will not be included. Participants will complete surveys about their health and feelings before starting the treatment, again after 12 weeks, and then every three months for a year. Overall, the study will last about 15 months and aims to provide better support for those affected by IPV.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients receiving care at an enrolled site/affiliated Community-Based Outpatient Clinic (CBOC)
- • report experience of past-year physical, psychological, and/or sexual IPV on an established screening tool used to detect IPV in VHA, and
- • be able to provide informed consent including permission to have intervention sessions recorded
- Exclusion Criteria:
- • severe cognitive impairment,
- • suicide or homicide intent with a specific plan
- • untreated or unstable symptoms of mania or psychosis
About Boston University
Boston University, a leading research institution located in Boston, Massachusetts, is dedicated to advancing health sciences through innovative clinical trials and research initiatives. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive network of experts and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes and addressing pressing health challenges. Boston University is committed to ethical research practices, patient safety, and the dissemination of findings to foster greater understanding and advancements in medical care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Minneapolis, Minnesota, United States
Philadelphia, Pennsylvania, United States
Patients applied
Trial Officials
Katherine M Iverson, PhD
Principal Investigator
V Boston Healthcare System, BU CASchool Medicine Psychiatry
Melissa Dichter, PhD MSW
Principal Investigator
VA Philadelphia Healthcare System
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported